Paul Brannelly

2013 - Karyopharm Therapeutics

In 2013, Paul Brannelly earned a total compensation of $2M as Senior Vice President, Finance and Administration at Karyopharm Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$117,960
Option Awards$1,702,879
Salary$160,505
Other$4,614
Total$1,985,958

Brannelly received $1.7M in option awards, accounting for 86% of the total pay in 2013.

Brannelly also received $118K in non-equity incentive plan, $160.5K in salary and $4.6K in other compensation.

Rankings

In 2013, Paul Brannelly's compensation ranked 3,922nd out of 12,286 executives tracked by ExecPay. In other words, Brannelly earned more than 68.1% of executives.

ClassificationRankingPercentile
All
3,922
out of 12,286
68th
Division
Manufacturing
1,326
out of 4,612
71st
Major group
Chemicals And Allied Products
359
out of 1,462
75th
Industry group
Drugs
251
out of 1,156
78th
Industry
Pharmaceutical Preparations
205
out of 890
77th
Source: SEC filing on April 28, 2014.

Brannelly's colleagues

We found two more compensation records of executives who worked with Paul Brannelly at Karyopharm Therapeutics in 2013.

2013

Michael Kauffman

Karyopharm Therapeutics

Chief Executive Officer

2013

Sharon Shacham

Karyopharm Therapeutics

Chief Scientific Officer

News

In-depth

You may also like